NLRP3 and colitis: Collectively, these findings illustrate that Lac16 alleviates colitis and provides gastrointestinal protection by suppressing NLRP3 inflammasome overactivation through a gut microbiota-dependent mechanism, with microbiota-derived isobutyric acid identified as the pivotal mediator in this protective process.